Conversion to everolimus in pediatric heart transplant recipients is a safe treatment option with an impact on cardiac allograft vasculopathy and renal function.

Autor:	Grimm, Kathrin1 (AUTHOR), Lehner, Anja1 (AUTHOR), Fernandez Rodriguez, Silvia1 (AUTHOR), Orban, Madeleine2 (AUTHOR), Fischer, Marcus1 (AUTHOR), Rosenthal, Laura L.3 (AUTHOR), Jakob, Andre1 (AUTHOR), Haas, Nikolaus A.1 (AUTHOR), Dalla Pozza, Robert1 (AUTHOR), Kozlik‐Feldmann, Rainer1,4 (AUTHOR), Ulrich, Sarah M.1 (AUTHOR) sarah.ulrich@med.uni-muenchen.de
Zdroj:	Clinical Transplantation. Mar2021, Vol. 35 Issue 3, p1-7. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu